Nuveen
ZYME icon

Nuveen’s Zymeworks ZYME Stock Holding History

Nuveen’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.12M Sell
119,389
-532,273
-82% -$13.5M ﹤0.01% 2353
2026
Q1 		$16.3M Buy
651,662
+3,336
+0.5% +$78.9K ﹤0.01% 1252
2025
Q4 		$17.1M Buy
648,326
+82,941
+15% +$1.81M ﹤0.01% 1233
2025
Q3 		$9.66M Sell
565,385
-89,531
-14% -$1.28M ﹤0.01% 1577
2025
Q2 		$8.22M Buy
654,916
+456,104
+229% +$5.43M ﹤0.01% 1630
2025
Q1 		$2.37M Sell
198,812
-8,211
-4% -$112K ﹤0.01% 2267
2024
Q4 		$3.03M Buy
207,023
+886
+0.4% +$12.4K ﹤0.01% 2215
2024
Q3 		$2.59M Buy
206,137
+527
+0.3% +$5.74K ﹤0.01% 2295
2024
Q2 		$1.75M Buy
205,610
+2,094
+1% +$18.6K ﹤0.01% 2451
2024
Q1 		$2.14M Buy
203,516
+8,534
+4% +$94.8K ﹤0.01% 2370
2023
Q4 		$2.03M Sell
194,982
-835
-0.4% -$6.66K ﹤0.01% 2407
2023
Q3 		$1.24M Sell
195,817
-45,983
-19% -$340K ﹤0.01% 2484
2023
Q2 		$2.09M Buy
+241,800
New +$2.16M ﹤0.01% 2326
2022
Q2 		– Sell
-36,322
Closed -$254K – 3513
2022
Q1 		$254K Buy
36,322
+3,008
+9% +$26.8K ﹤0.01% 3148
2021
Q4 		$546K Buy
+33,314
New +$695K ﹤0.01% 3055
2021
Q3 		– Sell
-70,351
Closed -$2.44M – 3453
2021
Q2 		$2.44M Buy
+70,351
New +$2.23M ﹤0.01% 2609
2021
Q1 		– Sell
-21,576
Closed -$1.02M – 3408
2020
Q4 		$1.02M Buy
21,576
+5,156
+31% +$239K ﹤0.01% 2798
2020
Q3 		$765K Sell
16,420
-28,706
-64% -$986K ﹤0.01% 2800
2020
Q2 		$1.63M Sell
45,126
-38,165
-46% -$1.41M ﹤0.01% 2425
2020
Q1 		$2.95M Buy
+83,291
New +$3.41M ﹤0.01% 1997

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Nuveen's ZYME Position: Q2 2026 in Review

Nuveen reduced its Zymeworks (ZYME) stake by 82% in Q2 2026, selling an estimated $13.5M and leaving 119,389 shares worth $3.12M. The position accounts for ﹤0.01% of the portfolio, ranked #2353.

Nuveen first reported a position in ZYME in Q1 2020 and has held it in 20 quarters since. The position peaked at $17.1M in Q4 2025. 202 funds tracked by Wall St. Rank hold ZYME as of Q2 2026.

  • Nuveen held 119,389 shares of Zymeworks worth $3.12M as of Q2 2026.
  • Nuveen sold 532,273 Zymeworks shares in Q2 2026, an estimated $13.5M.
  • Zymeworks made up ﹤0.01% of Nuveen's portfolio in Q2 2026, its #2353 holding.
  • Nuveen first reported a position in Zymeworks in Q1 2020 and has held it in 20 quarters since.
  • Nuveen's Zymeworks position peaked at $17.1M in Q4 2025.
  • 202 funds tracked by Wall St. Rank held Zymeworks as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.